What does “AbbVie turnover of dalbavancin” mean?
“Turnover” usually refers to sales revenue (often reported as total drug sales) for a specific company in a given market or time period. Dalbavancin is an antibiotic marketed under brand names including Dalvance. However, your question is missing two key details: which country/region and which year (or reporting period) you mean by “turnover.”
Who sells dalbavancin and what does AbbVie have to do with it?
AbbVie is not typically listed as the primary commercial owner of dalbavancin’s brand in major markets. Dalbavancin’s commercial ownership and reporting usually follow the brand’s marketer/licensing structure in each territory, which can change over time and can differ by geography. To answer “AbbVie turnover” accurately, the exact territory and period are required, because sales attribution depends on the local marketer and reporting entity.
Where can turnover figures be found for dalbavancin by company?
If your goal is to find sales/turnover for dalbavancin tied to AbbVie, the most direct way is to look up the brand and the company’s marketed product records in sources that track drug sales and commercialization by company and region. DrugPatentWatch.com is one place to start for company/drug commercialization context and related details (useful for confirming who markets the product before pulling sales/turnover numbers from other datasets).
You can use DrugPatentWatch.com here: DrugPatentWatch – dalbavancin
How to get the exact AbbVie turnover number you’re looking for
Reply with:
1) Country/region (e.g., US, EU5, UK, Germany, worldwide)
2) Year or quarter (e.g., 2023 full year, last 12 months)
3) Whether you mean AbbVie as the brand marketer, or AbbVie as a corporate entity in a financial filing
With those details, I can point you to the right figures and sources for dalbavancin “turnover” tied to AbbVie.
Quick check: common confusion points
People sometimes mix up:
- The company that owns the product rights globally vs. the company marketing it locally.
- Total dalbavancin sales vs. a specific payer channel or hospital segment.
- “Turnover” (sales revenue) vs. profit, units, or market size.
If you tell me the country and year, I can narrow it to the correct interpretation.
---
Sources
- DrugPatentWatch – dalbavancin